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IN THIS ISSUE 
UV A Irradiation and Skin Damage: A Deeper Look 
Petersen et al used a novel approach to study the nature of ultraviolet 
radiation damage to the skin. They hypothesized that UV A (320-
400 nm) or UVB (280 - 320 nm) might cause changes typical of sun 
exposure by stimulating the synthesis or activity of collagenase in 
the skin. To test this idea they irradiated monolayer cultures of 
neonatal and adult fibroblasts and keratinocytes with varying sub-
lethal doses of UVA or UVB light. Twenty-four hours later the 
relative levels of collagenase and TIMP (cellular collagenase inhibi-
tor) production were measured. Both neonatal and adult fibroblasts 
shoW'ed a net 2-13 times increase in collagenase mRNA and pro-
tein levels in response to UV A irradiation. UVB did not stimulate 
the response in fibroblasts and neither UV A nor UVB treatment 
altered the net collagenase production by keratinocytes. 
Other studies have shown that UVB contributes heavily to pho-
toaging. However, it is important to remember that the total dose of 
environmental UV A is 100 - 1000 times that of UVB. This study 
provides evidence that the more penetrating long-wave length 
UV A light may be a real factor in sun damage to the deeper levels of 
the dermis, where there is a higher concentration of fibroblasts. It 
will be interesting to use this approach for analysis of the effects of 
UVA and/or UVB on related members of the collagenase (matrix 
metalloproteinase) gene family . 
Proteoglycans, Glycosaminoglycans, and Developmental Regulation 
The epidermis is stratified epithelium in which there is a gradient of 
differentiation among the component cell types. Cells in the basal 
layer are mitotically active and give rise to keratinocytes that be-
come differentiated as they migrate outward. During stratification 
there is loss of cellular adherence to the extracellular matrix and 
formation of new and very specific intercellular interactions. Disso-
ciated keratinocytes and basal cells will reassort and interact with 
cells that are similarly differentiated. Changes in many types of 
adhesion and recognition molecules are likely to be involved in this 
developmental program. Proteoglycans (PG) have been shown to 
participate as recognition molecules for interactions with matrix as 
W'ell as with ligands and other macromolecules. They consist of a 
core protein with covalently attached glycosaminoglycans (GAG) 
such as heparan or chondroitan sulfate. These complex polyionic 
carbohydrates can be quite heterogeneous and are likely to contrib-
ute to the specific binding characteristics and cellular recognition 
properties of PG. . 
In this issue we present four papers that examine the expression of 
tW'o keratinocyte-specific proteoglycan families as well as glycosa-
rninoglycan free chains and their interrelationship with the regula-
tion of keratinocyte development. Sanderson et al analyzed stratifi-
cation-specific changes in syndecan-l that is known to act as a 
receptor for both extracellular matrix and growth factors. Two 
papers from the group headed by Leonard Milstone discuss the 
characterization of a newly cloned PG from human keratinocytes 
and its relationship to the CD44 family. Lastly, Piepkorn et al 
examined the generation of heparan sulfate free chains during the 
differentiation of human keratinocytes and proposed a role for these 
molecules. 
Syndecan-1 is a PG that has been assigned many modes ofinterac-
tion in epithelial cells. In simple epithelia, it is localized in the 
basolateral membranes and binds cells to extracellular matrix com-
ponents such as interstitial collagens. It also interacts with the cyto-
skeleton and is required for the maintenance of epithelial cell mor-
phology. In stratified epithelia, syndecan-1 is smaller in molecular 
mass and is arranged over the entire cell surface. Sanderson et al have 
used an in vitro system to stimulate differentiation of keratinocytes 
in vivo. By adding Ca++ to the medium, primary monolayer cul-
tures of mouse keratinocytes can be induced to stratify. Their data 
show that the core protein of syndecan-1 is the same size in mono-
layer and stratified cell cultures. The molecular polymorphism is 
due to a greater number and larger size of hepar an sulfate and chon-
droitan sulfate chains on the syndecan-1 of the simple epithelial 
mono layers. This form of syndecan-l has a higher binding affinity 
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for type I collagen. A parallel is drawn to changes seen with trans-
formation; contract inhibition is lost, cells become invasive after 
injection into nude athymic mice, and the smaller form of synde-
can-1 is produced. In addition, the extracellular domain of synde-
can-1 can be proteolytically cleaved, further affecting intercellular 
adhesion or the ability of the PG to bind growth or regulatory 
factors. An inference from these results is that the different forms of 
syndecan-1, polymorphic only in their GAG composition, have 
different adhesive characteristics and allow stratification and des-
quamation by providing gradually less interaction with the extra-
cellular matrix and/or other cells. 
A different program of expression is seen in the CD44 family of 
proteoglycans. Haggerty et al report the identification of epican, a 
keratinocyte-specific PG, isolated by generating monoclonal anti-
bodies directed at a purified keratinocyte PG preparation. The 
monoclonal antibody (MoAb 17) bound a PG with the apparent 
mobility of> 200-kDa and recognized an epitope of its 180-kDa 
core protein. Comparative Western blot analysis indicated that this 
antibody recognizes a subset of the CD44 family that is present only 
on epithelial cells in the skin. Previously identified CD44 PG attach 
chondroitin sulfate, whereas this form has either chondroitin or 
heparan sulfate. MoAb 17 also detected a low level of smaller core 
proteins, possibly indicating developmental regulation of CD44 
protein production in the differentiating keratinocytes. 
Kugelman et al pursued the question by using MoAb 17 to screen a 
human keratinocyte cDNA expression library. A clone encoding 
the entire core protein was sequenced. It identified epican as a novel 
form of the CD44 proteoglycans. Sequence data indicate that CD44 
PG in different human tissues result from alternative splicing of one 
single copy gene located on chromosome 11. Therefore, heteroge-
neity within the CD4"4 family results from differences in the core 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
protein itself, as well as in the amount and type of attached GAG. 
comparison of the various forms of CD44 indicates that differential 
exon usage may be related to modulation of functions such as the 
ability to bind hyaluronic acid, to metastasize, or to regulate growth 
factor activity. 
Recent experiments indicate that heparan sulfates may have a 
regulatory role in the mitogenic action of cytokines. GAG mole-
cules have been recovered as free chains from many cell types al-
though they are generally considered to function in proteoglycans. 
Piepkorn et al hypothesize that the GAG free chains arise by a 
normal processing of PG on the cell surface and may then bind 
ligands for intracellular transport. They take advantage of the polar-
ity of attached epidermal cells in culture to bind cationic colloidal 
silica beads to the exposed dorsal surface. After lysis of the cells, 
dorsal and ventral membrane surfaces, as well as intracellular com-
partments, can be identified and assayed for the presence of free 
GAG chains. Whereas the majority ofPG are associated with either 
dorsal or ventral membrane fraction in cultured keratinocytes and 
fibroblasts, only - 20% of free GAG chains are associated with 
peripheral membranes. The vast majority of these molecules are 
located in the supernatant fraction. They interpret these results to 
reflect a cell-surface origin followed by intracellular targeting of the 
free chains. These reports on the various changes in proteoglycan 
expression present an interesting picture. The heterogeneity that 
exists and the diversity of regulation points that are possible for 
expression is tremendous. Very sensitive discrimination for ligand 
interactions may occur through either the protein core or the cova-
lently associated GAG chains of PC. In addition, proteolysis of the 
core or endoglycosidase removal of GAG likely provide further 
means of regulating these associations. 
On the Origin of Birbeck Granules 
Langerhans cells (LC) are dendritic components of the epidermis 
that act as "professional" antigen-presenting cells for contact hyper-
sensitivity and for stimulation ofT-lymphocytes in vitro. They are 
characterized by a distinctive cytoplasmic organelle, the Birbeck 
granule (BG), thought to be involved in the process of antigen 
internalization by receptor-mediated endocytosis. Bucana et al 
previously demonstrated that after contact sensitization of the 
mouse skin, LC migrate to the draining lymph nodes where they 
present hapten to unsensitized T Iymphoctyes. These antigen-bear-
ing cells that contain BG and BG-like structures can be easily recov-
ered from cell suspensions for further study. In this issue, these 
investigators used a fluorescent tag to sensitize, identify, and isolate 
an enriched population ofLC that were functionally active. Tannic 
acid treatment and immunogold labeling of cell-surface class II 
MHC molecules provided the basis for ultrastructural analysis. LC 
from contact-sensitized mice showed many cored tubules, but few 
Birbeck granules, suggesting that the tubules are a response to cellu-
lar activation. Computer reconstruction of thin sections showed 
BG-like structures continuous from the surface membrane to the 
nuclear membrane in cells that were actively undergoing antibody 
internalization. Fluorescence monitoring showed rapid recycling of 
surface membrane, with internalization beginning at the coated 
vesticles. The data presented argue that BG-like structures derive 
from the cytomembrane in response to ligand-receptor interactions: 
Because no antigens were detected inside classical BG, it is unlikely 
that these organelles are formed during internalization. The associa-
tion of recognition molecules with BG-like structures strengthens 
the supposition that they are implicated in the antigen-processing 
and -presentation operations in Langerhans cells. 
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